A significant number of pediatric patients with immune thrombocytopenia (ITP) have difficulties with fatigue, emotional and behavioral symptoms, and executive functioning, with each having an effect on quality of life (QoL), according to a paper published in the British Journal of Haematology.
Fatigue, minor cognitive impairment, and overall reduction in health-related QoL are concerns in adults with ITP, but no studies have previously measured emotional and behavioral issues among pediatric patients. Therefore, pediatric patients are generally treated with a “watch and wait” approach.
- By Jonathan Goodman, MPhil for Hematology Advisor. Photo courtesty of pixabay.